SlideShare una empresa de Scribd logo
1 de 28
The Tuskegee Syphilis Study (1932-1972)




                    Benhur Pradeep


                            http://www.myclinicalresearchbook.blogspot.com
“In late July of 1972, Jean Heller of the Associated Press
  broke the story: for forty years the United States Public
Health Service had been conducting a study of the effects
     of untreated syphilis on black men in Macon County,
                                               Alabama…”
                                                           Bad Blood




                                           http://www.myclinicalresearchbook.blogspot.com
Background
 In exchange for their participation, the men were promised treatment,
  along with free meals, medical examinations, and burial insurance, but in
  reality received no substantial treatment
 - For example, the patients were misled into accepting mercury bands as a ‘treatment’
   when in fact these bands only acted as a screen for the physicians from the disease
   Additionally, doctors administered painful and potentially life crippling spinal taps not
   as a treatment or to improve their survival chances, but only as a method to collect
   data




                                                                   http://www.myclinicalresearchbook.blogspot.com
Background cont..
 Instead of informing patients they had syphilis and were contagious,
  doctors told patients they had "bad blood,” meaning several different
  illnesses, such as syphilis, anemia and fatigue
 - Thus, uninformed patients proceeded to spread the disease to their wives and children

 Although they later performed autopsies to examine the disease’s
  effects initially poor protocol was included
 - Study to last 6 –12 months A shift of focus to examine the aging process of the syphilis
   patients led to the longevity of the study lasting 40 years




                                                                  http://www.myclinicalresearchbook.blogspot.com
Penicillin
 TIn 1943 penicillin became a viable treatment for Syphilis
 Patients of the study did not receive penicillin treatment because doctors
  argued that it was a new development that had potential negative
  effects
 Despite the Henderson Act of 1943 and Alabama’s public health statutes,
  which was a public health law mandating the testing and treatment of
  individuals with tuberculosis and venereal diseases, penicillin was still
  not given to the patients




                                                        http://www.myclinicalresearchbook.blogspot.com
Syphilis: Overview
 Syphilis the AIDS of an earlier time.
 Syphilis is a sexually transmitted disease (STD) and Congenital. If it’s not
  treated, it can get worse over time and cause serious health problems.
 Syphilis is a sexually transmitted infection caused by Treponema
  pallidum.
 The problem was.., until 1907, no one could treat it.
 Nobel Prize winning-microbiologist. Paul Ehrlich discovered Salvarsan.
 An Arsenic based compound, and was the first chemotherapy.




                                                          http://www.myclinicalresearchbook.blogspot.com
The 1920‘s
 Progressive era in medicine.
 Armed with confidence and the scientific methods.
 U.S. Public Health Service officials were determined to control syphilis in
  their time.
 They set up free treatment clinics throughout the south, including Macon
  county, Alabama, home to the Tuskegee Institute.




                                                        http://www.myclinicalresearchbook.blogspot.com
The 1932
 The funding for treatment ran out.
 While writing the final report, Dr. Taliaferro Clark, head of the PHS
  Venereal Disease Division conceived an idea to salvage the study …
 Macon county “offered an unparalleled opportunity for the study of the
  effect of untreated syphilis” in the Negro male.




                                                         http://www.myclinicalresearchbook.blogspot.com
The Study of Untreated Syphilis in the Negro Male
 Was only supposed to last a year …
 but then Dr. Raymond Vondelehr advocated continuing the study to get
  autopsies.
 Autopsies would confirm clinical observation and therefore greatly
  contribute to the study’s scientific reliability.




                                                       http://www.myclinicalresearchbook.blogspot.com
“Bringing them to Autospy“
 By the time the story finally hit the newspapers in 1972,
 The experiment had gone on for 40 years.
 During all this time, it was no secret to the wider medical community.
 Results of the study had been published in well known medical journals.




                                                        http://www.myclinicalresearchbook.blogspot.com
Tuskegee Syphilis Study (1932 – 1972)
 July 25, 1972: story broke in Washington Star.
 600 low income African-American males from rural Alabama with a high
  incidence of syphilis infection were monitored for 40 years to observe
  course of disease.
 Given free medical exams but they were not told that they had syphilis.
 Cure (penicillin) became available in 1950s.
 Participants and families denied treatment.




                                                       http://www.myclinicalresearchbook.blogspot.com
“Newspaper Headlines“
 “A Violation of Human Dignity” (Houston Chronicle, Aug. 5, 1972)
 ”An Immoral Study” (St. Louis Post-Dispatch, July 30, 1972)
 “Inhuman Experiment” (Oregonian, July 31, 1972)
 “Blot on Humanity” (Chatanooga Times, July 28, 1972)
 “Cruel Experiment” (South Bend Tribune, July 29, 1972)
 “A Shocking Medical Experiment” (New Haven Register, July 29, 1972)
 “Humans as Guinea Pigs” (Richmond Times Dispatch, Aug. 6, 1972)
 “Official Inhumanity” (LA Times, July 27, 1972)
 “Horror Story” (Providence Sunday Journal, July 30, 1972)
 “Nightmare Experiment” (Raleigh News and Observer, July 28, 1972)
 “They Helped Men Die” (Milwaukee Journal, July 27, 1972)


                                                     http://www.myclinicalresearchbook.blogspot.com
Tuskegee Syphilis Study
 Overall question: HOW COULD IT HAVE HAPPENED?
 - How did it get started?
 - When did study actually begin?
 - Who proposed it?
 - Why?
 - What was goal of study?
 - Were there precedents?
 - Did anyone else approve the study?
 - Any difficulty securing subjects?
 - When was “one-time” study extended?
 - How was time extension possible?
 - How could treatment of subjects be prevented?
 - How did study continue after 1945 and discovery of penicillin?
 - How was the project finally ended?

                                                                    http://www.myclinicalresearchbook.blogspot.com
Q: How could it have happened?
 That as late as 1972 four hunered blacks were part of a government-run
  experiment, part of which was withhold treatment of syphilis.




                                                     http://www.myclinicalresearchbook.blogspot.com
Q: How did it get started?
 Like most research, for noble reasons. It followed studies in late 1920s to
  test & treat those least able to get diagnosis and treatment for syphilis:
  rural blacks.
 - pilot program in Miss. run by federal Public Health Service and Rosenwald Fund
   (foundation created explicitly to help blacks, later changed its focus to concentrate on
   health)
 - expanded in 1930 to other locations, including Macon Cty. Ala. (30 mi. east of
   Montgomery, 80% black). Tuskegee Inst. there, plus a veterans hospital. All black with
   22 doctors.
 - 1st stage: 7,000- 10,000 people tested; 36% tested positive (very high)
 - 2nd stage was treatment with Salvarsan and mercury; 1200 treated by fall of 1930.
   After another year, high cost and limited effect made Rosenwald announce end of
   program. State of Ala. could not pick up cost; nor could PHS (until 1934).




                                                                    http://www.myclinicalresearchbook.blogspot.com
Q: When, Who, Why and Goal?
 Tuskegee study of untreated syphilis in Negro male began between 1931
  and 1934.
 Taliferro Clark, a PHS worker who came to Alabama during Rosenwald
  study.
 Preferred to treat but no funding for it. Clark noted that of initial 1400
  admitted for treatment, only 33 had undergone any previous treatment.
 To learn about effects of syphilis on blacks; to see if it was different than
  on whites (racist assumption?)




                                                           http://www.myclinicalresearchbook.blogspot.com
Q: Were there precedents?

 Only anecdotal observations of blacks. Nothing systematic or large scale.
  But in 1928 an article in a German journal was published with results of a
  Norwegian study of several hundred untreated patients between 1891-
  1910. Of note were great frequency in cardiovascular damage, and only
  rare neurological damage. Common assumptions was that in blacks there
  was higher frequency of neurological damage. (NOTE: Norwegian study
  was done before even salvarsan, let alone penicillin was available.)




                                                        http://www.myclinicalresearchbook.blogspot.com
Q: Did anyone else approve the study?
 Yes
 Discussed with PHS colleagues, all approved
 Ala. State Board of Health approved, on condition that all were treated.
  No problem since Clark initially proposed a 6-8 month study; treatment,
  when funds available, took a year. Ala. also wanted local doctors to
  participate
 Tuskegee hospital medical director agreed to be local medical
  participant.
 Protocol submitted to Johns Hopkins Medical School doctors, who
  suggested study of males, over 25, 2-300 size of sample, insure no
  previous treatment.



                                                      http://www.myclinicalresearchbook.blogspot.com
Q: Any diffulty securing subjects?
 No, because it was deliberately confused with earlier testing and
  treatment.

Q: When was time of study extended?
 By April 1933 results showed little neurological damage. Idea was first
  suggested that for little expense, subjects could be observed for 5-10
  years to produce more information. Subjects already identified and
  participating.
 June 1933 Clark retired and was succeeded by new PHS doctor, Raymond
  Vonderlehr. He proposed to follow subjects to autopsy, because so much
  more info could be learned.



                                                     http://www.myclinicalresearchbook.blogspot.com
Q: How was time extension possible?
 Little question about it. Most important was agreement of local doctors,
  because they would not provide treatment. Most subjects were indigent.
 Nurse Eunice Rivers hired, crucial to keeping men in program. She assured them
  and suggested “burial stipend” as incentive. (funded by Milbank Memorial
  Fund).




                                                           http://www.myclinicalresearchbook.blogspot.com
Q: How could treatment be prevented?
 TIn 1937 Rosenwald finally renewed funding of treatment program; in
  1939 a mobile PHS treatment program was assigned to Macon Cty.
 Nurse Rivers screened men, saying they were under study; several men
  prevented from treatment 1939-41. Her justification: doctor’s orders and
  treatment had side effects. After 1942 draft physicals given (pos. tests
  required treatment; Vonderlehr got exemptions).

Q: How did study continue after 1945 and Penicillin?
 As new officials came across the study and raised questions (1948, 1951,
  1952), other PHS officials regarded it as a “never to be repeated
  opportunity”; 20 years invested in experiment.




                                                      http://www.myclinicalresearchbook.blogspot.com
Q: How was the project finally ended?
 TAll along articles were published on results. As late as June 1965 a
  doctor in Detroit hospital (Irwin Schatz) read a 1964 article and sent a
  letter to PHS (“I am utterly astounded by the fact that physicians allow
  patients with a potentially fatal disease to remain untreated when
  effective therapy is available.”) It was filed in CDC with note it was first
  such letter. No reply written.
 Peter Buxtun first heard of Tuskegee when hired at SF VD clinic in Dec.
  1965. Curiosity and required paper made him research Tuskegee articles
  (sent by CDC). Based on his reading Buxtun sent a letter in Nov. 1966
  questioning the study. No reply, but a CDC official visited him over
  Christmas to talk to Buxtun, and he was invited to Atlanta for a meeting a
  few months later. But no change in CDC policy.



                                                         http://www.myclinicalresearchbook.blogspot.com
Q: How was the project finally ended?
 Nov. 1967 Buxtun resigned from VD clinic; fall 1968 he entered law school in SF;
  Nov. 1968 he wrote another letter to CDC. Now (post MLK assassination riots) it
  got attention. Feb. 1969 an ad hoc committee met at CDC, serious debate about
  ending experiment, but in the end it decided to continue. Also, consent to
  continue was asked from Macon Cty. Medical Society (now mostly black). The
  men still alive (56 with syphilis and 36 control) would be monitored until their
  death.
 CDC wrote this back to Buxtun who was still in law school. He talked to a few
  colleagues (one suggested the ACLU file a suit), but Buxtun left it until he
  mentioned it to a friend who was a reporter for the AP, who became very
  interested. It was Feb. 1972. Another reporter, Jean Heller, in Washington got
  the assignment and the story broke on July 25, 1972.
 An assistant secretary of HEW responded he was “shocked and horrified” at the
  report. Another ad hoc panel was immediately created (Aug. 24, 1972); Feb.
  1973 Sen. Kennedy began hearings.

                                                            http://www.myclinicalresearchbook.blogspot.com
Tuskegee Syphilis Study: In short

    July 25,   • Story breaks in Washington Star
     1972



    Aug. 24,   • Ad hoc panel created at PHS to review experiment
     1972


               • Panel recommends ending the study
   Oct. 1972



   Feb.-Mar. • Edward Kennedy begins Senate hearings
     1973


               • HEW Secretary (Weinberger) orders treatment for subjects in
    Mar. 3,      study
    1973


                                                                    http://www.myclinicalresearchbook.blogspot.com
Tuskegee Syphilis Study: In short

             • $1.8 billion lawsuit filed by patients and families
 July 1973



             • New guidelines for human subject experiments
   1974


             • Govt. settles lawsuit ($37,500 to each living survivor
   Dec.        and $15,000 to heirs)
   1974


             • Govt. extended treatment to wives and children who
   1975        had contracted syphilis


             • Clinton apologizes in person to 4 of the 8 survivors
   1997



                                                                        http://www.myclinicalresearchbook.blogspot.com
Tuskegee Syphilis Study -

         Became a major factor in the writing of the 1979



                    Belmont Report

 which guides human subject research today in the U.S and others.




                                                 http://www.myclinicalresearchbook.blogspot.com
Basic Principles of Belmont Report
 The 3 basic ethical principles of Belmont report are
 - Autonomy
 - Beneficence
 - Justice




                                                         http://www.myclinicalresearchbook.blogspot.com
Thank
                            You
 Benhur Pradeep
 pradeep.ben84@gmail.com




www.presentationpoint.com




                               http://www.myclinicalresearchbook.blogspot.com

Más contenido relacionado

La actualidad más candente

Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical researchRegulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical researchDr. Harisha S
 
Belmont report
Belmont reportBelmont report
Belmont reportPradeep H
 
Nuremberg code
Nuremberg codeNuremberg code
Nuremberg codePradeep H
 
Ethical Considerations In Clinical Trials
Ethical  Considerations In  Clinical  TrialsEthical  Considerations In  Clinical  Trials
Ethical Considerations In Clinical Trialskrathishbopanna
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trialAnju Thejkumar
 
Ethics in clinical trials
Ethics in clinical trialsEthics in clinical trials
Ethics in clinical trialsUrmila Aswar
 
Case report form and application
Case report  form  and  applicationCase report  form  and  application
Case report form and applicationIrene Vadakkan
 
Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2heba rashed
 
The Belmont Report (Three Benchmark Rules)
The Belmont Report (Three Benchmark Rules)The Belmont Report (Three Benchmark Rules)
The Belmont Report (Three Benchmark Rules)ClinosolIndia
 
Informed consent in Clinical Trials
Informed consent in Clinical TrialsInformed consent in Clinical Trials
Informed consent in Clinical TrialsKaushik Mukhopadhyay
 
The ethics of clinical trials
The ethics of clinical trialsThe ethics of clinical trials
The ethics of clinical trialseliweber1980
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data ManagementMahesh Koppula
 
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINESICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINESDR. RANJEET PRASAD
 
ICMR ethical guidelines for biomedical research .pptx
ICMR ethical guidelines for biomedical research .pptxICMR ethical guidelines for biomedical research .pptx
ICMR ethical guidelines for biomedical research .pptxkamalinsan
 
History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trialsUrmila Aswar
 
ICH GCP guidelines
ICH GCP guidelinesICH GCP guidelines
ICH GCP guidelinesrx_sonali
 
Ethical issues in medical research
Ethical issues in medical researchEthical issues in medical research
Ethical issues in medical researchDr. Manoj Kumbhare
 

La actualidad más candente (20)

Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical researchRegulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
 
Belmont report
Belmont reportBelmont report
Belmont report
 
The Nuremberg Code
The Nuremberg CodeThe Nuremberg Code
The Nuremberg Code
 
Nuremberg code
Nuremberg codeNuremberg code
Nuremberg code
 
Ethics in clinical research
Ethics in clinical researchEthics in clinical research
Ethics in clinical research
 
Ethical Considerations In Clinical Trials
Ethical  Considerations In  Clinical  TrialsEthical  Considerations In  Clinical  Trials
Ethical Considerations In Clinical Trials
 
History ethical guide lines to clinical trial
History ethical guide lines to clinical trialHistory ethical guide lines to clinical trial
History ethical guide lines to clinical trial
 
Ethics in clinical trials
Ethics in clinical trialsEthics in clinical trials
Ethics in clinical trials
 
Case report form and application
Case report  form  and  applicationCase report  form  and  application
Case report form and application
 
Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2Essential Documents of Clinical Trials_2
Essential Documents of Clinical Trials_2
 
The Belmont Report (Three Benchmark Rules)
The Belmont Report (Three Benchmark Rules)The Belmont Report (Three Benchmark Rules)
The Belmont Report (Three Benchmark Rules)
 
Informed consent in Clinical Trials
Informed consent in Clinical TrialsInformed consent in Clinical Trials
Informed consent in Clinical Trials
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
The ethics of clinical trials
The ethics of clinical trialsThe ethics of clinical trials
The ethics of clinical trials
 
Clinical Data Management
Clinical Data ManagementClinical Data Management
Clinical Data Management
 
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINESICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
ICH-GCP AND THEIR DIFFIRENCES TO INDIAN CLINICAL TRIAL GUIDELINES
 
ICMR ethical guidelines for biomedical research .pptx
ICMR ethical guidelines for biomedical research .pptxICMR ethical guidelines for biomedical research .pptx
ICMR ethical guidelines for biomedical research .pptx
 
History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trials
 
ICH GCP guidelines
ICH GCP guidelinesICH GCP guidelines
ICH GCP guidelines
 
Ethical issues in medical research
Ethical issues in medical researchEthical issues in medical research
Ethical issues in medical research
 

Similar a Tuskegee study

PRS565Tuskegee and guatemala 2016
PRS565Tuskegee and guatemala 2016PRS565Tuskegee and guatemala 2016
PRS565Tuskegee and guatemala 2016emphemory
 
tuskegeepresentation.pptx
tuskegeepresentation.pptxtuskegeepresentation.pptx
tuskegeepresentation.pptxBrendaBlunt2
 
Synopsis reverby 'normal exposure'
Synopsis reverby 'normal exposure'Synopsis reverby 'normal exposure'
Synopsis reverby 'normal exposure'bueno buono good
 
Cleveland State University[email protected]Journal of Law
Cleveland State University[email protected]Journal of Law Cleveland State University[email protected]Journal of Law
Cleveland State University[email protected]Journal of Law WilheminaRossi174
 
Medical Ethics
 Medical Ethics Medical Ethics
Medical EthicsMona Mofti
 
Unethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - WikiUnethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - WikiNot Relevant
 
Individuals On The Front Line of Tuskegee Syphilis Study - Before & After
Individuals On The Front Line of Tuskegee Syphilis Study - Before & AfterIndividuals On The Front Line of Tuskegee Syphilis Study - Before & After
Individuals On The Front Line of Tuskegee Syphilis Study - Before & AfterMuhammad Hamza Shah
 
Tuskegee Syphilis Study.pptx
Tuskegee Syphilis Study.pptxTuskegee Syphilis Study.pptx
Tuskegee Syphilis Study.pptxAmandaRisley1
 
Bureacracy in Action: A Review of "Bad Blood"
Bureacracy in Action: A Review of "Bad Blood"Bureacracy in Action: A Review of "Bad Blood"
Bureacracy in Action: A Review of "Bad Blood"Haley Shoemaker
 
2. health ethics intro
2. health ethics intro2. health ethics intro
2. health ethics introMesfin Tafa
 
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docxNATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docxvannagoforth
 
Good clinical practices
Good clinical practicesGood clinical practices
Good clinical practicesDhruva Sharma
 

Similar a Tuskegee study (15)

Back to Tuskegee
Back to TuskegeeBack to Tuskegee
Back to Tuskegee
 
Tuskegee tests
Tuskegee testsTuskegee tests
Tuskegee tests
 
PRS565Tuskegee and guatemala 2016
PRS565Tuskegee and guatemala 2016PRS565Tuskegee and guatemala 2016
PRS565Tuskegee and guatemala 2016
 
tuskegeepresentation.pptx
tuskegeepresentation.pptxtuskegeepresentation.pptx
tuskegeepresentation.pptx
 
Synopsis reverby 'normal exposure'
Synopsis reverby 'normal exposure'Synopsis reverby 'normal exposure'
Synopsis reverby 'normal exposure'
 
Cleveland State University[email protected]Journal of Law
Cleveland State University[email protected]Journal of Law Cleveland State University[email protected]Journal of Law
Cleveland State University[email protected]Journal of Law
 
Medical Ethics
 Medical Ethics Medical Ethics
Medical Ethics
 
Unethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - WikiUnethical human experimentation in the United States - Wiki
Unethical human experimentation in the United States - Wiki
 
Individuals On The Front Line of Tuskegee Syphilis Study - Before & After
Individuals On The Front Line of Tuskegee Syphilis Study - Before & AfterIndividuals On The Front Line of Tuskegee Syphilis Study - Before & After
Individuals On The Front Line of Tuskegee Syphilis Study - Before & After
 
Tuskegee Syphilis Study.pptx
Tuskegee Syphilis Study.pptxTuskegee Syphilis Study.pptx
Tuskegee Syphilis Study.pptx
 
Bureacracy in Action: A Review of "Bad Blood"
Bureacracy in Action: A Review of "Bad Blood"Bureacracy in Action: A Review of "Bad Blood"
Bureacracy in Action: A Review of "Bad Blood"
 
Tutor 9 bhp sg 15
Tutor 9   bhp sg 15Tutor 9   bhp sg 15
Tutor 9 bhp sg 15
 
2. health ethics intro
2. health ethics intro2. health ethics intro
2. health ethics intro
 
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docxNATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
 
Good clinical practices
Good clinical practicesGood clinical practices
Good clinical practices
 

Más de Pradeep H

ICH 20th Anniversary_value_benefits_of_ich_for_regulators
ICH 20th Anniversary_value_benefits_of_ich_for_regulatorsICH 20th Anniversary_value_benefits_of_ich_for_regulators
ICH 20th Anniversary_value_benefits_of_ich_for_regulatorsPradeep H
 
The Declaration of Helsinki
The Declaration of HelsinkiThe Declaration of Helsinki
The Declaration of HelsinkiPradeep H
 
Declaration Of Helsinki
Declaration Of HelsinkiDeclaration Of Helsinki
Declaration Of HelsinkiPradeep H
 
The Nuremberg trials
The Nuremberg trialsThe Nuremberg trials
The Nuremberg trialsPradeep H
 
Clinical research milestones
Clinical research milestonesClinical research milestones
Clinical research milestonesPradeep H
 
The Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History LessonThe Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History LessonPradeep H
 
Clinical trials: Terminology
Clinical trials: TerminologyClinical trials: Terminology
Clinical trials: TerminologyPradeep H
 
Clinical trials history
Clinical trials historyClinical trials history
Clinical trials historyPradeep H
 
Introduction to clinical research - II
Introduction to clinical research - IIIntroduction to clinical research - II
Introduction to clinical research - IIPradeep H
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical researchPradeep H
 

Más de Pradeep H (11)

ICH 20th Anniversary_value_benefits_of_ich_for_regulators
ICH 20th Anniversary_value_benefits_of_ich_for_regulatorsICH 20th Anniversary_value_benefits_of_ich_for_regulators
ICH 20th Anniversary_value_benefits_of_ich_for_regulators
 
The Declaration of Helsinki
The Declaration of HelsinkiThe Declaration of Helsinki
The Declaration of Helsinki
 
ICH
ICHICH
ICH
 
Declaration Of Helsinki
Declaration Of HelsinkiDeclaration Of Helsinki
Declaration Of Helsinki
 
The Nuremberg trials
The Nuremberg trialsThe Nuremberg trials
The Nuremberg trials
 
Clinical research milestones
Clinical research milestonesClinical research milestones
Clinical research milestones
 
The Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History LessonThe Evolution of the Clinical Trials Process – A Brief History Lesson
The Evolution of the Clinical Trials Process – A Brief History Lesson
 
Clinical trials: Terminology
Clinical trials: TerminologyClinical trials: Terminology
Clinical trials: Terminology
 
Clinical trials history
Clinical trials historyClinical trials history
Clinical trials history
 
Introduction to clinical research - II
Introduction to clinical research - IIIntroduction to clinical research - II
Introduction to clinical research - II
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical research
 

Último

97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 

Último (20)

97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 

Tuskegee study

  • 1. The Tuskegee Syphilis Study (1932-1972) Benhur Pradeep http://www.myclinicalresearchbook.blogspot.com
  • 2. “In late July of 1972, Jean Heller of the Associated Press broke the story: for forty years the United States Public Health Service had been conducting a study of the effects of untreated syphilis on black men in Macon County, Alabama…” Bad Blood http://www.myclinicalresearchbook.blogspot.com
  • 3. Background  In exchange for their participation, the men were promised treatment, along with free meals, medical examinations, and burial insurance, but in reality received no substantial treatment - For example, the patients were misled into accepting mercury bands as a ‘treatment’ when in fact these bands only acted as a screen for the physicians from the disease Additionally, doctors administered painful and potentially life crippling spinal taps not as a treatment or to improve their survival chances, but only as a method to collect data http://www.myclinicalresearchbook.blogspot.com
  • 4. Background cont..  Instead of informing patients they had syphilis and were contagious, doctors told patients they had "bad blood,” meaning several different illnesses, such as syphilis, anemia and fatigue - Thus, uninformed patients proceeded to spread the disease to their wives and children  Although they later performed autopsies to examine the disease’s effects initially poor protocol was included - Study to last 6 –12 months A shift of focus to examine the aging process of the syphilis patients led to the longevity of the study lasting 40 years http://www.myclinicalresearchbook.blogspot.com
  • 5. Penicillin  TIn 1943 penicillin became a viable treatment for Syphilis  Patients of the study did not receive penicillin treatment because doctors argued that it was a new development that had potential negative effects  Despite the Henderson Act of 1943 and Alabama’s public health statutes, which was a public health law mandating the testing and treatment of individuals with tuberculosis and venereal diseases, penicillin was still not given to the patients http://www.myclinicalresearchbook.blogspot.com
  • 6. Syphilis: Overview  Syphilis the AIDS of an earlier time.  Syphilis is a sexually transmitted disease (STD) and Congenital. If it’s not treated, it can get worse over time and cause serious health problems.  Syphilis is a sexually transmitted infection caused by Treponema pallidum.  The problem was.., until 1907, no one could treat it.  Nobel Prize winning-microbiologist. Paul Ehrlich discovered Salvarsan.  An Arsenic based compound, and was the first chemotherapy. http://www.myclinicalresearchbook.blogspot.com
  • 7. The 1920‘s  Progressive era in medicine.  Armed with confidence and the scientific methods.  U.S. Public Health Service officials were determined to control syphilis in their time.  They set up free treatment clinics throughout the south, including Macon county, Alabama, home to the Tuskegee Institute. http://www.myclinicalresearchbook.blogspot.com
  • 8. The 1932  The funding for treatment ran out.  While writing the final report, Dr. Taliaferro Clark, head of the PHS Venereal Disease Division conceived an idea to salvage the study …  Macon county “offered an unparalleled opportunity for the study of the effect of untreated syphilis” in the Negro male. http://www.myclinicalresearchbook.blogspot.com
  • 9. The Study of Untreated Syphilis in the Negro Male  Was only supposed to last a year …  but then Dr. Raymond Vondelehr advocated continuing the study to get autopsies.  Autopsies would confirm clinical observation and therefore greatly contribute to the study’s scientific reliability. http://www.myclinicalresearchbook.blogspot.com
  • 10. “Bringing them to Autospy“  By the time the story finally hit the newspapers in 1972,  The experiment had gone on for 40 years.  During all this time, it was no secret to the wider medical community.  Results of the study had been published in well known medical journals. http://www.myclinicalresearchbook.blogspot.com
  • 11. Tuskegee Syphilis Study (1932 – 1972)  July 25, 1972: story broke in Washington Star.  600 low income African-American males from rural Alabama with a high incidence of syphilis infection were monitored for 40 years to observe course of disease.  Given free medical exams but they were not told that they had syphilis.  Cure (penicillin) became available in 1950s.  Participants and families denied treatment. http://www.myclinicalresearchbook.blogspot.com
  • 12. “Newspaper Headlines“  “A Violation of Human Dignity” (Houston Chronicle, Aug. 5, 1972)  ”An Immoral Study” (St. Louis Post-Dispatch, July 30, 1972)  “Inhuman Experiment” (Oregonian, July 31, 1972)  “Blot on Humanity” (Chatanooga Times, July 28, 1972)  “Cruel Experiment” (South Bend Tribune, July 29, 1972)  “A Shocking Medical Experiment” (New Haven Register, July 29, 1972)  “Humans as Guinea Pigs” (Richmond Times Dispatch, Aug. 6, 1972)  “Official Inhumanity” (LA Times, July 27, 1972)  “Horror Story” (Providence Sunday Journal, July 30, 1972)  “Nightmare Experiment” (Raleigh News and Observer, July 28, 1972)  “They Helped Men Die” (Milwaukee Journal, July 27, 1972) http://www.myclinicalresearchbook.blogspot.com
  • 13. Tuskegee Syphilis Study  Overall question: HOW COULD IT HAVE HAPPENED? - How did it get started? - When did study actually begin? - Who proposed it? - Why? - What was goal of study? - Were there precedents? - Did anyone else approve the study? - Any difficulty securing subjects? - When was “one-time” study extended? - How was time extension possible? - How could treatment of subjects be prevented? - How did study continue after 1945 and discovery of penicillin? - How was the project finally ended? http://www.myclinicalresearchbook.blogspot.com
  • 14. Q: How could it have happened?  That as late as 1972 four hunered blacks were part of a government-run experiment, part of which was withhold treatment of syphilis. http://www.myclinicalresearchbook.blogspot.com
  • 15. Q: How did it get started?  Like most research, for noble reasons. It followed studies in late 1920s to test & treat those least able to get diagnosis and treatment for syphilis: rural blacks. - pilot program in Miss. run by federal Public Health Service and Rosenwald Fund (foundation created explicitly to help blacks, later changed its focus to concentrate on health) - expanded in 1930 to other locations, including Macon Cty. Ala. (30 mi. east of Montgomery, 80% black). Tuskegee Inst. there, plus a veterans hospital. All black with 22 doctors. - 1st stage: 7,000- 10,000 people tested; 36% tested positive (very high) - 2nd stage was treatment with Salvarsan and mercury; 1200 treated by fall of 1930. After another year, high cost and limited effect made Rosenwald announce end of program. State of Ala. could not pick up cost; nor could PHS (until 1934). http://www.myclinicalresearchbook.blogspot.com
  • 16. Q: When, Who, Why and Goal?  Tuskegee study of untreated syphilis in Negro male began between 1931 and 1934.  Taliferro Clark, a PHS worker who came to Alabama during Rosenwald study.  Preferred to treat but no funding for it. Clark noted that of initial 1400 admitted for treatment, only 33 had undergone any previous treatment.  To learn about effects of syphilis on blacks; to see if it was different than on whites (racist assumption?) http://www.myclinicalresearchbook.blogspot.com
  • 17. Q: Were there precedents?  Only anecdotal observations of blacks. Nothing systematic or large scale. But in 1928 an article in a German journal was published with results of a Norwegian study of several hundred untreated patients between 1891- 1910. Of note were great frequency in cardiovascular damage, and only rare neurological damage. Common assumptions was that in blacks there was higher frequency of neurological damage. (NOTE: Norwegian study was done before even salvarsan, let alone penicillin was available.) http://www.myclinicalresearchbook.blogspot.com
  • 18. Q: Did anyone else approve the study?  Yes  Discussed with PHS colleagues, all approved  Ala. State Board of Health approved, on condition that all were treated. No problem since Clark initially proposed a 6-8 month study; treatment, when funds available, took a year. Ala. also wanted local doctors to participate  Tuskegee hospital medical director agreed to be local medical participant.  Protocol submitted to Johns Hopkins Medical School doctors, who suggested study of males, over 25, 2-300 size of sample, insure no previous treatment. http://www.myclinicalresearchbook.blogspot.com
  • 19. Q: Any diffulty securing subjects?  No, because it was deliberately confused with earlier testing and treatment. Q: When was time of study extended?  By April 1933 results showed little neurological damage. Idea was first suggested that for little expense, subjects could be observed for 5-10 years to produce more information. Subjects already identified and participating.  June 1933 Clark retired and was succeeded by new PHS doctor, Raymond Vonderlehr. He proposed to follow subjects to autopsy, because so much more info could be learned. http://www.myclinicalresearchbook.blogspot.com
  • 20. Q: How was time extension possible?  Little question about it. Most important was agreement of local doctors, because they would not provide treatment. Most subjects were indigent.  Nurse Eunice Rivers hired, crucial to keeping men in program. She assured them and suggested “burial stipend” as incentive. (funded by Milbank Memorial Fund). http://www.myclinicalresearchbook.blogspot.com
  • 21. Q: How could treatment be prevented?  TIn 1937 Rosenwald finally renewed funding of treatment program; in 1939 a mobile PHS treatment program was assigned to Macon Cty.  Nurse Rivers screened men, saying they were under study; several men prevented from treatment 1939-41. Her justification: doctor’s orders and treatment had side effects. After 1942 draft physicals given (pos. tests required treatment; Vonderlehr got exemptions). Q: How did study continue after 1945 and Penicillin?  As new officials came across the study and raised questions (1948, 1951, 1952), other PHS officials regarded it as a “never to be repeated opportunity”; 20 years invested in experiment. http://www.myclinicalresearchbook.blogspot.com
  • 22. Q: How was the project finally ended?  TAll along articles were published on results. As late as June 1965 a doctor in Detroit hospital (Irwin Schatz) read a 1964 article and sent a letter to PHS (“I am utterly astounded by the fact that physicians allow patients with a potentially fatal disease to remain untreated when effective therapy is available.”) It was filed in CDC with note it was first such letter. No reply written.  Peter Buxtun first heard of Tuskegee when hired at SF VD clinic in Dec. 1965. Curiosity and required paper made him research Tuskegee articles (sent by CDC). Based on his reading Buxtun sent a letter in Nov. 1966 questioning the study. No reply, but a CDC official visited him over Christmas to talk to Buxtun, and he was invited to Atlanta for a meeting a few months later. But no change in CDC policy. http://www.myclinicalresearchbook.blogspot.com
  • 23. Q: How was the project finally ended?  Nov. 1967 Buxtun resigned from VD clinic; fall 1968 he entered law school in SF; Nov. 1968 he wrote another letter to CDC. Now (post MLK assassination riots) it got attention. Feb. 1969 an ad hoc committee met at CDC, serious debate about ending experiment, but in the end it decided to continue. Also, consent to continue was asked from Macon Cty. Medical Society (now mostly black). The men still alive (56 with syphilis and 36 control) would be monitored until their death.  CDC wrote this back to Buxtun who was still in law school. He talked to a few colleagues (one suggested the ACLU file a suit), but Buxtun left it until he mentioned it to a friend who was a reporter for the AP, who became very interested. It was Feb. 1972. Another reporter, Jean Heller, in Washington got the assignment and the story broke on July 25, 1972.  An assistant secretary of HEW responded he was “shocked and horrified” at the report. Another ad hoc panel was immediately created (Aug. 24, 1972); Feb. 1973 Sen. Kennedy began hearings. http://www.myclinicalresearchbook.blogspot.com
  • 24. Tuskegee Syphilis Study: In short July 25, • Story breaks in Washington Star 1972 Aug. 24, • Ad hoc panel created at PHS to review experiment 1972 • Panel recommends ending the study Oct. 1972 Feb.-Mar. • Edward Kennedy begins Senate hearings 1973 • HEW Secretary (Weinberger) orders treatment for subjects in Mar. 3, study 1973 http://www.myclinicalresearchbook.blogspot.com
  • 25. Tuskegee Syphilis Study: In short • $1.8 billion lawsuit filed by patients and families July 1973 • New guidelines for human subject experiments 1974 • Govt. settles lawsuit ($37,500 to each living survivor Dec. and $15,000 to heirs) 1974 • Govt. extended treatment to wives and children who 1975 had contracted syphilis • Clinton apologizes in person to 4 of the 8 survivors 1997 http://www.myclinicalresearchbook.blogspot.com
  • 26. Tuskegee Syphilis Study -  Became a major factor in the writing of the 1979 Belmont Report  which guides human subject research today in the U.S and others. http://www.myclinicalresearchbook.blogspot.com
  • 27. Basic Principles of Belmont Report  The 3 basic ethical principles of Belmont report are - Autonomy - Beneficence - Justice http://www.myclinicalresearchbook.blogspot.com
  • 28. Thank You Benhur Pradeep pradeep.ben84@gmail.com www.presentationpoint.com http://www.myclinicalresearchbook.blogspot.com